Eucrisa
crisaborole
Listed by Pfizer Laboratories Div Pfizer Inc
- Strength
- 20 mg/g
- Form
- Ointment
- Route
- Topical
- Class
- Phosphodiesterase 4 Inhibitor
What it contains
- Crisaborole 20 mg/g
FDA record
| Dosage form | Ointment |
|---|---|
| Route | Topical |
| Drug class | Phosphodiesterase 4 Inhibitor |
| Approval route | NDA — original brand approval |
| NDC code | 55724-211 |
| FDA application | NDA207695 |
| RxNorm concept | 1865957 |
| Package sizes listed | 4 |
| Marketed since | January 2017 |
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.